Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors

BACKGROUND: Lung cancer is the second most common cancer worldwide, with non-small-cell lung cancer (NSCLC) accounting for the majority of cases. Patients with NSCLC have achieved great survival benefits from immunotherapies targeting immune checkpoints. Glucocorticoids (GCs) are frequently used for...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Nijiao, Zheng, Xuliang, Gan, Jinyan, Zhuo, Ting, Li, Xiaohong, Yang, Chuyi, Wu, Yanbin, Qin, Shouming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617908/
https://www.ncbi.nlm.nih.gov/pubmed/37925595
http://dx.doi.org/10.1097/CM9.0000000000002544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617908/
https://www.ncbi.nlm.nih.gov/pubmed/37925595
http://dx.doi.org/10.1097/CM9.0000000000002544

Ejemplares similares